CSE: 2017-0507 - New Listing - Lexington Biosciences Inc. (LNB)

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 05/05/17 -- The common shares of Lexington Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

Les actions ordinaires de Lexington Biosciences Inc. ont ete approuvees pour inscription sur le CSE.

Les documents d'inscription et de divulgation seront disponibles sur

Lexington Biosciences, Inc. est une entreprise de dispositifs medicaux de developpement qui opere dans le secteur de la sante. Lexington se concentre sur le developpement et la commercialisation de produits non invasifs de surveillance de la sante cardiovasculaire pour permettre un diagnostic predictif des evenements cardiovasculaires futurs. L'objectif actuel de l'entreprise est de developper et commercialiser le produit de mesure de la fonction endotheliale HeartSentry.





Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 05.05.2017 - 17:15 Uhr
Sprache: Deutsch
News-ID 540626
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO

Kategorie:

Investment Services & Trading

Diese Pressemitteilung wurde bisher 212 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"CSE: 2017-0507 - New Listing - Lexington Biosciences Inc. (LNB)"
steht unter der journalistisch-redaktionellen Verantwortung von

Canadian Securities Exchange (CSE) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

CSE: 2017-1109 - Name and Symbol Change and Consolidation - Big Rock Labs Inc. ( ...

TORONTO, ONTARIO -- (Marketwired) -- 11/17/17 -- Big Rock Labs Inc. has announced a name change to Blox Labs Inc. and a share consolidation of its issued and outstanding common shares on a one (1) post consolidation share for each two (2) pre-conso ...

CSE: 2017-1108 - New Listing - eXeBlock Technology Corporation (XBLK) ...

TORONTO, ONTARIO -- (Marketwired) -- 11/15/17 -- The common shares of eXeBlock Technology Corporation have been approved for listing on the CSE.Listing and disclosure documents will be available at .eXeBlock Technology Corporation is a designer of ...

CSE: 2017-1107 - New Listing - Black Tusk Resources Inc. (TUSK) ...

TORONTO, ONTARIO -- (Marketwired) -- 11/07/17 -- The common shares of Black Tusk Resources Inc. have been approved for listing on the CSE.The shares will be deemed to be listed on November 8, 2017, in anticipation of closing the Prospectus Offering ...

Alle Meldungen von Canadian Securities Exchange (CSE)